Atropos Health, the leader in translating real-world clinical data into high-quality personalized real-world evidence for care, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the AI and Data category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries and on society at large.
Inc.’s Best in Business list recognizes companies that, through exceptional execution, have achieved significant milestones and core business wins, like customer expansion, key product launches, increased market share, and industry-defining accomplishments. Companies from a wide range of industries—such as technology, health care, finance, and retail—have been recognized for their success and positive influence on the business world. The full list can be found on Inc.com and in the upcoming winter print edition of Inc. magazine.
“For over 40 years, Inc. has been committed to recognizing America’s most dynamic businesses and honoring their great work. These businesses have had a profound impact on their industries, solving important problems and shaping the future of business in ways that will have lasting effects,” says Inc. editor-in-chief Mike Hofman.
Inc.’s Best in Business Awards are open to companies of all sizes and types in all industries and locations. Public, private, nonprofit, subsidiary, U.S.-based, and international companies are all encouraged to apply. Inc. editors and reporters hand-review every application and select Best in Business honorees that, in each of the award categories, have had an outstanding influence on their communities, their industries, the environment, or society as a whole.
“Our achievements this year reflect the incredible dedication and innovation of our team, partners, and collaborators,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “From launching ChatRWD™, the first generative AI application to deliver full observational studies on healthcare data in minutes, to expanding the Atropos Evidence™ Network into the largest federated data network in healthcare, Atropos Health is making strides in precision medicine by empowering clinicians and researchers with high-quality, personalized evidence. The real-world evidence (RWE) generated from Atropos Health continues to benefit clinicians and researchers with care protocols and clinical trial design that improve patient outcomes and reduce the time from symptom to treatment. Together, we are redefining the boundaries of what’s possible in healthcare.”
This year, Atropos Health raised $33 million in Series B funding to scale the automation of high-quality, personalized, real-world evidence. The Atropos Evidence™ Network, the largest federated data network, expanded to over 300 million patient records. The company also released ChatRWD™, its healthcare generative AI tool, which reduces the time to produce high-quality, publication-grade real-world evidence from months to minutes.
With the increasing popularity and adoption of AI in healthcare, Atropos Health is committed to the responsible deployment of technology, ensuring the uses of AI meet the highest quality standards required for healthcare. One example of this is prior to the release of ChatRWD, an independent study comparing ChatRWD to other general-purpose and healthcare large language models (LLMs) was published. The study found that ChatRWD outperformed all other LLMs, completing 94 percent of the answers and delivering the best answers for novel questions in 87 percent of the cases. ChatRWD is purpose-built for healthcare and an example of Atropos Health’s commitment to quality, accuracy and transparency in methodology to drive results for healthcare stakeholders.
For more information or to see the complete list, please visit inc.com/best-in-business.
About Atropos Health
Atropos Health is the developer of GENEVA OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence. For more information, visit https://www.atroposhealth.com/
About Inc.
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.’s award-winning work achieves a monthly brand footprint of more than 40 million across a variety of channels, including events, digital, print, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an exclusive community of their peers, and credibility that helps them drive sales and recruit talent. For more information, visit https://www.inc.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203312871/en/